Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis. – ScienceOpen
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To evaluate the efficacy of infliximab (IFX, 5-10 mg/kg) (Group 1) and tocilizumab (TCZ, 4-8 mg/kg) (Group 2) infusions in non-infectious retinal vasculitis (RV) using Angiographic Scoring for the Uveitis Working Group fluorescein angiography (FA) scoring system.

          Related collections

          Author and article information

          Journal
          Eye (Lond)
          Eye (London, England)
          Springer Science and Business Media LLC
          1476-5454
          0950-222X
          Aug 2023
          : 37
          : 11
          Affiliations
          [1 ] Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
          [2 ] Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA, USA. ndquan@stanford.edu.
          Article
          10.1038/s41433-022-02315-9
          10.1038/s41433-022-02315-9
          10366079
          36443499
          9c6029a2-fe82-4cda-ba7b-bfbf4985bdc1
          History

          Comments

          Comment on this article